Mustang Bio (MBIO) Interest Coverage Ratio (2016 - 2025)
Mustang Bio (MBIO) posted quarterly Interest Coverage Ratio of 2.94 for Q1 2025, up 84.87% year-over-year from 1.59 in Q1 2024, and up 62.97% quarter-over-quarter from 7.95 in Q4 2024.
Mustang Bio (MBIO) Interest Coverage Ratio (2016 - 2025) Analysis & Trends
Mustang Bio (MBIO) has reported Interest Coverage Ratio for 10 consecutive years, with 2.94 the latest figure, recorded in Q1 2025.
- In Q1 2025, Interest Coverage Ratio rose 84.87% year-over-year to 2.94; the TTM figure through Dec 2025 stood at 28.28 (up 77.37% YoY), while the FY2025 annual figure was 28.28, down 26377.36% from the prior year.
- Interest Coverage Ratio climbed to 2.94 in Q1 2025 per MBIO's latest filing, from 7.95 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 2913.67 in Q4 2023 and bottomed at 5692.33 in Q3 2021.
- Historically, Interest Coverage Ratio has averaged 921.47 across 5 years, with a median of 19.45 in 2024.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio sank 146589.36% — and 2023, when it soared 50285.48%.
- Mustang Bio's Interest Coverage Ratio stood at 5029.75 in 2021, then jumped by 99.88% to 5.81 in 2022, then jumped by 50285.48% to 2913.67 in 2023, then tumbled by 100.27% to 7.95 in 2024, then soared by 62.97% to 2.94 in 2025.
- Business Quant data shows MBIO's Interest Coverage Ratio at 2.94 in Q1 2025, 7.95 in Q4 2024, and 1457.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.42 |
| 10 | Mustang Bio | 3.87 Mn | 3.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.94 |
| Dec 31, 2024 | -7.95 |
| Sep 30, 2024 | -1,457.00 |
| Jun 30, 2024 | -2.93 |
| Mar 31, 2024 | -19.45 |
| Dec 31, 2023 | 2,913.67 |
| Sep 30, 2023 | -2,576.75 |
| Jun 30, 2023 | -4.74 |
| Mar 31, 2023 | -15.94 |
| Dec 31, 2022 | -5.81 |
| Sep 30, 2022 | -18.23 |
| Jun 30, 2022 | -19.51 |
| Mar 31, 2022 | -85.38 |
| Dec 31, 2021 | -5,029.75 |
| Sep 30, 2021 | -5,692.33 |
| Jun 30, 2021 | -3,610.00 |
| Mar 31, 2021 | -29.99 |
| Dec 31, 2020 | -8.86 |
| Sep 30, 2020 | -3.88 |
| Jun 30, 2020 | -22.81 |